Association of time of breakfast and nighttime fasting duration with breast cancer risk in the multicase-control study in Spain.

breakfast breast cancer risk chrononutrition circadian nutritional behaviors circadian rhythms meal timing nighttime fasting duration

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2022
Historique:
received: 11 05 2022
accepted: 18 07 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Circadian nutritional behaviors, defined by the daily eating/fasting cycle, have been linked with breast cancer. This study aimed to further disentangle the association of nighttime fasting duration and time of breakfast with breast cancer risk. We analyzed data from 1,181 breast cancer cases and 1,326 population controls from the Spanish multicase-control study (MCC-Spain), 2008-2013. We collected circadian nutritional behaviors at mid-age

Identifiants

pubmed: 36034928
doi: 10.3389/fnut.2022.941477
pmc: PMC9404378
doi:

Types de publication

Journal Article

Langues

eng

Pagination

941477

Informations de copyright

Copyright © 2022 Palomar-Cros, Harding, Espinosa, Papantoniou, Pérez-Gómez, Straif, Ardanaz, Fernández Villa, Amiano, Gómez-Acebo, Moreno, Alguacil, Fernández-Tardón, Molina-Barceló, Marcos-Gragera, Aragonés, Castaño-Vinyals, Guevara, Marcos Delgado, Pollán, Romaguera and Kogevinas.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2018 Jun 29;13(6):e0199622
pubmed: 29958276
PLoS One. 2015 Aug 25;10(8):e0136240
pubmed: 26305095
Lancet Oncol. 2007 Dec;8(12):1065-6
pubmed: 19271347
Lancet Oncol. 2019 Aug;20(8):1058-1059
pubmed: 31281097
Front Physiol. 2019 Jun 25;10:682
pubmed: 31293431
Prev Med. 2011 Oct;53(4-5):260-7
pubmed: 21925535
Lancet Glob Health. 2020 Aug;8(8):e1027-e1037
pubmed: 32710860
Physiol Behav. 2015 Mar 1;140:215-21
pubmed: 25545767
Cancer Causes Control. 2021 May;32(5):505-513
pubmed: 33590466
Chronobiol Int. 2014 Feb;31(1):64-71
pubmed: 24094031
Am J Clin Nutr. 2017 Jun;105(6):1351-1361
pubmed: 28490511
Nutr Diabetes. 2020 Feb 19;10(1):6
pubmed: 32075959
PLoS One. 2018 Oct 31;13(10):e0206669
pubmed: 30379940
Int J Cancer. 2018 Nov 15;143(10):2380-2389
pubmed: 30016830
Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):783-9
pubmed: 25896523
Curr Nutr Rep. 2014 Apr 27;3:204-212
pubmed: 25101217
Diabetes Care. 2017 Nov;40(11):1573-1579
pubmed: 28830875
J Neurochem. 2021 Apr;157(1):53-72
pubmed: 33222161
Med Sci Sports Exerc. 1993 Jan;25(1):71-80
pubmed: 8292105
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nutrition. 2021 Oct;90:111245
pubmed: 33964488
JAMA Oncol. 2016 Aug 1;2(8):1049-55
pubmed: 27032109
Obesity (Silver Spring). 2020 Jun;28(6):1098-1109
pubmed: 32304359
Biomolecules. 2021 Mar 24;11(4):
pubmed: 33804974
Br J Surg. 1969 Oct;56(10):764-6
pubmed: 5347580
Nutr Metab (Lond). 2012 Sep 10;9(1):78
pubmed: 22963033
Front Nutr. 2021 Jul 01;8:681436
pubmed: 34277681
Nutrients. 2021 Jul 30;13(8):
pubmed: 34444822
Breast Cancer Res. 2011 Apr 21;13(2):208
pubmed: 21575279
Br J Nutr. 2015 Aug 14;114(3):347-57
pubmed: 26173770
Nutrients. 2021 Jan 19;13(1):
pubmed: 33477881
Int J Cancer. 2018 Nov 15;143(10):2369-2379
pubmed: 29744870
Public Health Nutr. 2021 Jul;24(10):2936-2943
pubmed: 32583754
Eur J Epidemiol. 2018 Apr;33(4):369-379
pubmed: 29464445
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680

Auteurs

Anna Palomar-Cros (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Barbara N Harding (BN)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.

Ana Espinosa (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.

Kyriaki Papantoniou (K)

Department of Epidemiology, Centre of Public Health, Medical University of Vienna, Vienna, Austria.

Beatriz Pérez-Gómez (B)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Kurt Straif (K)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Boston College, Chestnut Hill, MA, United States.

Eva Ardanaz (E)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Tania Fernández Villa (T)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Research Group on Gene-Environment Interactions and Health (GIIGAS), Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, Gipuzkoa, Spain.
Group of Epidemiology of Chronic and Communicable Diseases, Biodonostia Health Research Institute, San Sebastián, Gipuzkoa, Spain.

Inés Gómez-Acebo (I)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Faculty of Medicine, University of Cantabria, Santander, Spain.

Victor Moreno (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Cancer Epidemiology Research Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Juan Alguacil (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Centre for Health and Environmental Research, Huelva University, Huelva, Spain.

Guillermo Fernández-Tardón (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Unit of Molecular Cancer Epidemiology, Department of Medicine, University Institute of Oncology of the Principality of Asturias (IOUPA), University of Oviedo, Oviedo, Spain.
Health Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain.

Ana Molina-Barceló (A)

Cancer and Public Health Area, Foundation for the Promotion of the Research in Healthcare and Biomedicine (FISABIO-Salud Pública), Valencia, Spain.

Rafael Marcos-Gragera (R)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdiBGi), Girona, Spain.

Nuria Aragonés (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Gemma Castaño-Vinyals (G)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.

Marcela Guevara (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Alba Marcos Delgado (A)

Research Group on Gene-Environment Interactions and Health (GIIGAS), Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain.

Marina Pollán (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Dora Romaguera (D)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain.

Manolis Kogevinas (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.

Classifications MeSH